MicroRNAs in acute leukemia: from biological players to clinical contributors
暂无分享,去创建一个
M. D. Boer | R. Pieters | R. Pieters | D. Schotte | R Pieters | D Schotte | ML Den Boer
[1] K. Basso,et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. , 2007, Cancer cell.
[2] M. D. Boer,et al. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia , 2011, Leukemia.
[3] Donglin Cao,et al. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia , 2010, Proceedings of the National Academy of Sciences.
[4] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[5] C. Croce,et al. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. , 2009, Blood.
[6] Zhiguo Wang,et al. The principles of MiRNA-masking antisense oligonucleotides technology. , 2011, Methods in molecular biology.
[7] C. Pui,et al. Biology and treatment of acute lymphoblastic leukemia , 1994 .
[8] M. Cleary,et al. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. , 2010, Cancer research.
[9] S. Papageorgiou,et al. The role of microRNAs in normal and malignant hematopoiesis , 2010, European journal of haematology.
[10] Aadel A. Chaudhuri,et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder , 2008, The Journal of experimental medicine.
[11] F. Slack,et al. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.
[12] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[13] R. Siebert,et al. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] D. Brown,et al. The promise of microRNA replacement therapy. , 2010, Cancer research.
[15] M. Caligiuri,et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Patrick J. Paddison,et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia , 2010, Nature Cell Biology.
[17] A. van den Berg,et al. BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.
[18] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[19] Hui Zhou,et al. Genome-Wide Analysis of Small RNA and Novel MicroRNA Discovery in Human Acute Lymphoblastic Leukemia Based on Extensive Sequencing Approach , 2009, PloS one.
[20] Torsten Haferlach,et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin , 2008, Proceedings of the National Academy of Sciences.
[21] C. Croce,et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] L. Cope,et al. A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells. , 2008, Cancer research.
[23] Noam Shomron,et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 , 2009, Leukemia.
[24] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[25] Caifu Chen,et al. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia , 2011, Haematologica.
[26] Judy Lieberman,et al. Promise and Challenge of Rna Interference–based Therapy for Cancer Journal of Clinical Oncology B I O L O G Y O F N E O P L a S I A , 2010 .
[27] Beiyan Zhou,et al. MicroRNA miR-125b causes leukemia , 2010, Proceedings of the National Academy of Sciences.
[28] S. Armstrong,et al. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 Acute Lymphocytic Leukemia cells , 2010, Cell cycle.
[29] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[30] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[31] M. Caligiuri,et al. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] G. Ruvkun,et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.
[33] Andrea Califano,et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.
[34] T. Du,et al. Asymmetry in the Assembly of the RNAi Enzyme Complex , 2003, Cell.
[35] Kathryn A. O’Donnell,et al. Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.
[36] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[37] Stefano Volinia,et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[38] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[39] T. Dingermann,et al. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. , 2010, Blood.
[40] C. Croce,et al. MicroRNAs in normal and malignant hematopoiesis , 2008, Current opinion in hematology.
[41] Peter A. Jones,et al. Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.
[42] Guido Marcucci,et al. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. , 2008, Cancer research.
[43] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[44] S. Armstrong,et al. miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. , 2008, Blood.
[45] T Chaplin,et al. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis , 2007, Leukemia.
[46] J. Rowley,et al. Leukaemogenesis: more than mutant genes , 2010, Nature Reviews Cancer.
[47] N. Zeleznik-Le,et al. MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets. , 2010, Current drug targets.
[48] C. Burge,et al. Identification of let-7-regulated oncofetal genes. , 2008, Cancer research.
[49] Liang-Hu Qu,et al. MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia , 2009, PloS one.
[50] J. Rowley,et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. , 2009, Blood.
[51] C. Bloomfield,et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.
[52] Wayne Tam,et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] Xian-Ming Chen,et al. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation , 2010, British journal of haematology.
[54] F. Slack,et al. The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure , 2008, Cell cycle.
[55] M. Caligiuri,et al. Prognostic Importance of MN 1 Transcript Levels , and Biologic Insights From MN 1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia : A Cancer and Leukemia Group B Study , 2009 .
[56] Margaret S. Ebert,et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.
[57] Christian Langer,et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] Beth Israel,et al. Decision letter: Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010 .
[59] Jiuhong Kang,et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.
[60] Hui Zhang,et al. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. , 2010, Cancer cell.
[61] Yijun Qi,et al. DNA methylation mediated by a microRNA pathway. , 2010, Molecular cell.
[62] Y. Pekarsky,et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.
[63] R. Stam,et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. , 2010, Blood.
[64] Patricia Soteropoulos,et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. , 2007, Cancer research.
[65] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[66] M. Caligiuri,et al. miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts , 2010, Cell.
[67] A. van den Berg,et al. miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC/miR‐155 expression , 2008, The Journal of pathology.
[68] R. Yeh,et al. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. , 2010, Blood.
[69] M. Caligiuri,et al. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] Scott A. Armstrong,et al. MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.
[71] R. Pieters,et al. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale , 2011, Leukemia.
[72] Dominique Leroux,et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation , 2008, The Journal of experimental medicine.
[73] R. Siebert,et al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. , 2009, Cancer research.
[74] George A Calin,et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. , 2008, Blood.
[75] R. Arceci. Consistent Deregulation of Gene Expression between Human and Murine MLL Rearrangement Leukemias , 2009 .
[76] S. K. Zaidi,et al. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. , 2009, Cancer research.
[77] Hiroyuki Tagawa,et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. , 2009, Blood.
[78] E. Thiel,et al. The Role of Microrna-196a-1 and Microrna-196b in Acute T-Lymphoblastic Leukemia and Acute Myeloid Leukemia. , 2009 .
[79] H. Lodish,et al. MicroRNAs as regulators of mammalian hematopoiesis. , 2005, Seminars in immunology.
[80] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[81] Bob Löwenberg,et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.
[82] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[83] Phillip A Sharp,et al. MicroRNA sponges: progress and possibilities. , 2010, RNA.
[84] Ryan D. Morin,et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. , 2009, Blood.
[85] Ryan D. Morin,et al. Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.
[86] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[87] C. Croce,et al. MicroRNA 29b functions in acute myeloid leukemia. , 2009, Blood.
[88] R. Pieters,et al. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia , 2012, Pediatric blood & cancer.
[89] Jean-Baptiste Cazier,et al. Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia , 2008, PloS one.
[90] J. Cigudosa,et al. Genetic and Epigenetic Silencing of microRNA-203 Enhances ABL 1 and BCR-ABL 1 Oncogene Expression , 2008 .
[91] W. Evans,et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. , 2009, The Lancet. Oncology.
[92] Y. Pekarsky,et al. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation , 2010, Leukemia.
[93] S. Orkin,et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.
[94] T. Golub,et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations , 2008, Proceedings of the National Academy of Sciences.
[95] S. Kauppinen,et al. Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.
[96] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[97] R. Stam,et al. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia , 2010, Haematologica.
[98] M. D. Boer,et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia , 2009, Leukemia.
[99] R. Stam,et al. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. , 2009, Blood.